Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Cryptococcosis | Research

Identification of risk factors for disseminated cryptococcosis in non-hiv patients: a retrospective analysis

Authors: Fan Zhang, Yiqing Zhou, Xiaoqi Tang, Minghui Li

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Objective

This study aimed to investigate the potential risk factors associated with disseminated cryptococcosis in HIV-negative individuals.

Methods

A total of 106 HIV-negative patients with cryptococcal disease were enrolled. The observation group consisted of patients with disseminated cryptococcosis (DC), whereas the control groups included patients with pulmonary cryptococcosis (PC) and cryptococcal meningitis (CM). Univariate and multivariate logistic regression algorithms were used to explore the significant clinical and laboratory characteristics that affect the progression of cryptococcal infections. Finally, receiver operating characteristics (ROC) curves are applied to assess the diagnostic value of identified risk factors.LE: Kindly check the edit made in the title.I agree

Results

Of the 106 patients, 57 were diagnosed with pulmonary cryptococcosis, 22 with cryptococcal meningitis, and 27 with disseminated cryptococcosis. The logistic regression equation included five variables: diabetes, decompensated liver cirrhosis, long-term use of immunosuppressive agents, decreased serum albumin level, and elevated plasma cytokine IL-10 level. The ROC curves showed that albumin (AUC > 0.7), IL-10 (AUC > 0.7) and decompensated liver cirrhosis (AUC > 0.6) have relatively high diagnostic capacity in predicting the progression of Cryptococcus.

Conclusion

This study identified elevated IL-10 levels as an independent risk factor for developing disseminated cryptococcosis in the control groups. Furthermore, decompensated liver cirrhosis and decreased serum albumin independently affected the progression of cryptococcosis in the CM and PC groups, respectively.
Literature
1.
go back to reference Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis. 2006;10:72–8.CrossRefPubMed Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis. 2006;10:72–8.CrossRefPubMed
2.
go back to reference Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19:454–66.CrossRefPubMedPubMedCentral Iyer KR, Revie NM, Fu C, Robbins N, Cowen LE. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19:454–66.CrossRefPubMedPubMedCentral
3.
go back to reference Gullo FP, et al. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol. 2013;32:1377–91.CrossRef Gullo FP, et al. Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol. 2013;32:1377–91.CrossRef
4.
go back to reference Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 2015;78:7–15.CrossRefPubMed Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 2015;78:7–15.CrossRefPubMed
5.
go back to reference Surawut S, et al. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans. Sci Rep. 2017;7:40006.CrossRefPubMedPubMedCentral Surawut S, et al. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans. Sci Rep. 2017;7:40006.CrossRefPubMedPubMedCentral
6.
go back to reference Kitai Y, et al. Role of dectin-2 in the phagocytosis of cryptococcus neoformans by dendritic cells. Infect Immun. 2021;89: e0033021.CrossRefPubMed Kitai Y, et al. Role of dectin-2 in the phagocytosis of cryptococcus neoformans by dendritic cells. Infect Immun. 2021;89: e0033021.CrossRefPubMed
7.
go back to reference Ou XT, et al. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients. J Infect Dis. 2011;203:1686–91.CrossRefPubMed Ou XT, et al. Genotypes coding for mannose-binding lectin deficiency correlated with cryptococcal meningitis in HIV-uninfected Chinese patients. J Infect Dis. 2011;203:1686–91.CrossRefPubMed
10.
go back to reference Yuchong C, et al. Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia. 2012;173:329–35.CrossRefPubMed Yuchong C, et al. Cryptococcosis in China (1985–2010): review of cases from Chinese database. Mycopathologia. 2012;173:329–35.CrossRefPubMed
11.
go back to reference Chiller T, Farrokhshad K, Brummer E, Stevens DA. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Med Mycol. 2002;40:21–6.CrossRefPubMed Chiller T, Farrokhshad K, Brummer E, Stevens DA. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Med Mycol. 2002;40:21–6.CrossRefPubMed
12.
go back to reference Mariano Andrade R, Monteiro Almeida G, Alexandre DosReis G, Bento AM, C. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cellular Immunol. 2003;222:116–25.CrossRef Mariano Andrade R, Monteiro Almeida G, Alexandre DosReis G, Bento AM, C. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses. Cellular Immunol. 2003;222:116–25.CrossRef
13.
go back to reference Wormley FL Jr, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007;75:1453–62.CrossRefPubMedPubMedCentral Wormley FL Jr, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007;75:1453–62.CrossRefPubMedPubMedCentral
14.
go back to reference Hernandez Y, et al. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol. 2005;174:1027–36.CrossRefPubMed Hernandez Y, et al. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol. 2005;174:1027–36.CrossRefPubMed
15.
go back to reference Teitz-Tennenbaum S, et al. Autocrine IL-10 signaling promotes dendritic cell type-2 activation and persistence of murine cryptococcal lung infection. J Immunol. 2018;201:2004–15.CrossRefPubMed Teitz-Tennenbaum S, et al. Autocrine IL-10 signaling promotes dendritic cell type-2 activation and persistence of murine cryptococcal lung infection. J Immunol. 2018;201:2004–15.CrossRefPubMed
16.
go back to reference Singh N, et al. Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes. Transplantation. 2015;99:2132–41.CrossRefPubMed Singh N, et al. Cryptococcosis in patients with cirrhosis of the liver and posttransplant outcomes. Transplantation. 2015;99:2132–41.CrossRefPubMed
19.
20.
go back to reference Wolf JM, Rivera J, Casadevall A. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles. Cell Microbiol. 2012;14:762–73.CrossRefPubMed Wolf JM, Rivera J, Casadevall A. Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles. Cell Microbiol. 2012;14:762–73.CrossRefPubMed
22.
go back to reference Kelley JL, Strum M, Riche DM, Chandler AM. Sodium glucose transporter 2 inhibitors and diabetic ketoacidosis in three patients with diabetes: underlying causation. J Pharmacol Pharmacother. 2017;8:137–9.PubMedPubMedCentral Kelley JL, Strum M, Riche DM, Chandler AM. Sodium glucose transporter 2 inhibitors and diabetic ketoacidosis in three patients with diabetes: underlying causation. J Pharmacol Pharmacother. 2017;8:137–9.PubMedPubMedCentral
23.
go back to reference Gulcan A, Gulcan E, Oksuz S, Sahin I, Kaya D. Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors. J Am Podiatr Med Assoc. 2011;101:49–54.CrossRefPubMed Gulcan A, Gulcan E, Oksuz S, Sahin I, Kaya D. Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors. J Am Podiatr Med Assoc. 2011;101:49–54.CrossRefPubMed
24.
go back to reference Li J, Zhang Q, Su B. Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome. J Int Med Res. 2017;45:2139–45.CrossRefPubMedPubMedCentral Li J, Zhang Q, Su B. Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome. J Int Med Res. 2017;45:2139–45.CrossRefPubMedPubMedCentral
25.
go back to reference Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clinics North Am. 2001;15:423–32.CrossRef Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clinics North Am. 2001;15:423–32.CrossRef
28.
go back to reference Li KK, Jin GY, Kweon KS. Cryptococcus pneumonia: Helpful findings for diagnosing cryptococcal pneumonia on CT in residents. J Clin Images Med Case Rep. 2022;3:1630.CrossRef Li KK, Jin GY, Kweon KS. Cryptococcus pneumonia: Helpful findings for diagnosing cryptococcal pneumonia on CT in residents. J Clin Images Med Case Rep. 2022;3:1630.CrossRef
29.
go back to reference Hu Y, Ren SY, Xiao P, Yu FL, Liu WL. The clinical and radiological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients. BMC Pulm Med. 2021;21:262.CrossRefPubMedPubMedCentral Hu Y, Ren SY, Xiao P, Yu FL, Liu WL. The clinical and radiological characteristics of pulmonary cryptococcosis in immunocompetent and immunocompromised patients. BMC Pulm Med. 2021;21:262.CrossRefPubMedPubMedCentral
30.
31.
go back to reference Baddley JW, Forrest GN. Cryptococcosis in solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33: e13543.CrossRefPubMed Baddley JW, Forrest GN. Cryptococcosis in solid organ transplantation-guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33: e13543.CrossRefPubMed
32.
go back to reference Fisher KM, Montrief T, Ramzy M, Koyfman A, Long B. Cryptococcal meningitis: a review for emergency clinicians. Intern Emerg Med. 2021;16:1031–42.CrossRefPubMed Fisher KM, Montrief T, Ramzy M, Koyfman A, Long B. Cryptococcal meningitis: a review for emergency clinicians. Intern Emerg Med. 2021;16:1031–42.CrossRefPubMed
33.
34.
go back to reference Vena A, et al. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2019;62:441–9.CrossRefPubMed Vena A, et al. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2019;62:441–9.CrossRefPubMed
35.
go back to reference Bongomin F, et al. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations. Eur J Clin Microbiol Infect Dis. 2019;38:1581–4.CrossRefPubMed Bongomin F, et al. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations. Eur J Clin Microbiol Infect Dis. 2019;38:1581–4.CrossRefPubMed
Metadata
Title
Identification of risk factors for disseminated cryptococcosis in non-hiv patients: a retrospective analysis
Authors
Fan Zhang
Yiqing Zhou
Xiaoqi Tang
Minghui Li
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01592-8

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue